Michelle Cooper, MD
Obstetrics & Gynecology · Dover, DENPI 1275517922
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,785 of the $3,343 with a category attached, or 83.3%. It is spread thinly across 32 manufacturers, the largest accounting for just 17.9% — the pattern of someone who eats at a lot of different presentations. Among obstetrics & gynecology clinicians in DE with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 176 payments — averaging $18.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$600
- AbbVie$556
- Evofem Biosciences, Inc.$519
- Exeltis, USA Inc.$162
- Myovant Sciences Inc.$160
- Sumitomo Pharma America, Inc.$155
- plus $1K from 26 others
What the payments were for
- Food & beverage$2,78583%
- Education$55817%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 22 | $600 |
| AbbVie(2 entities) | 31 | $556 |
| Evofem Biosciences, Inc. | 31 | $519 |
| Exeltis, USA Inc. | 10 | $162 |
| Myovant Sciences Inc. | 10 | $160 |
| Sumitomo Pharma America, Inc. | 8 | $155 |
| Organon | 7 | $140 |
| AMAG Pharmaceuticals, Inc. | 8 | $112 |
| Exact Sciences | 5 | $106 |
| Millicent US Inc | 6 | $101 |
| Scynexis, Inc. | 4 | $94 |
| Sage Therapeutics, LLC | 4 | $79 |
| IBSA Pharma Inc. | 4 | $73 |
| Therapeuticsmd, Inc. | 4 | $69 |
| Novo Nordisk | 2 | $44 |
| Abbott | 2 | $39 |
| Merck | 2 | $34 |
| Pfizer | 2 | $31 |
| Lilly USA, LLC | 1 | $28 |
| Boston Scientific | 1 | $28 |
| Davol Inc. | 1 | $24 |
| Acella Pharmaceuticals, LLC | 1 | $21 |
| Aspira Women's Health Inc | 1 | $21 |
| Bayer | 1 | $19 |
| Coopersurgical, Inc. | 1 | $18 |
| Arjo Inc. | 1 | $18 |
| Amgen | 1 | $18 |
| Smith+Nephew | 1 | $16 |
| Amarin Pharma, Inc. | 1 | $16 |
| BD | 1 | $15 |
| Urovant Sciences Inc | 1 | $14 |
| Hologic Sales And Service, LLC | 1 | $14 |
How this compares
$3,343 in reported general payments places this provider in the 90th percentile of 139 obstetrics & gynecology providers in Delaware.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 169 | $18,377 |
| ProgesteroneProgesterone, Micronized | 177 | $10,930 |
| Estradiol (Twice Weekly)Estradiol | 88 | $10,453 |
| MyrbetriqMirabegron | 11 | $7,991 |
| DottiEstradiol | 28 | $5,315 |
| Liothyronine Sodium | 73 | $2,584 |
| Clobetasol Propionate | 37 | $1,934 |
| Levothyroxine Sodium | 87 | $1,812 |
| Spironolactone | 16 | $734 |
| Np ThyroidThyroid,pork | 19 | $616 |
| SynthroidLevothyroxine Sodium | 13 | $564 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 13 | $520 |
| ValacyclovirValacyclovir Hcl | 15 | $448 |
| Alendronate Sodium | 41 | $441 |
| Fluconazole | 40 | $241 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $600 | $7,99111 claims |
| Acella Pharmaceuticals, LLCNp Thyroid | $21 | $61619 claims |
| AbbVieSynthroid | $556 | $56413 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 139 obstetrics & gynecology providers in Delaware.
Other obstetrics & gynecology in Dover
- Robert HartmannDover$393K
- Robert ScacheriDover$5K
- Peter WongDover$4K
- Laura MoylanDover$2K
- Ian BaxterSeaford$157K
- Larry GlazermanWilmington$31K
- Anthony BellNewark$17K
- Richard DermanNewark$14K
- Steven BerlinLewes$7K
- Gordon OstrumNewark$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.